Intraepithelial and invasive squamous neoplasms of the conjunctiva in Ibadan, Nigeria: a clinicopathological study of 46 cases.
OBJECTIVE
To retrospectively evaluate the clinicopathological features, treatment modalities and factors affecting prognosis in patients with both conjunctival intraepithelial and invasive squamous neoplasms.


METHODS
Review and analysis of clinical and pathological records of all cases histologically diagnosed in the Department of Pathology, University College Hospital, Ibadan, Nigeria between January 1990 and December 2004.


RESULTS
There were a total of 46 cases in 45 patients (eight intraepithelial carcinomas, 37 invasive squamous cell carcinomas (SCC) and a single case of mucoepidermoid carcinoma in a 71-year-old man). The intraepithelial neoplasms occurred in patients aged between 20 and 90 years. Seven of these patients had actinic changes on histology. For invasive SCC, patients' ages ranged from 18 to 84 years with a mean age of 53 years. Male to female ratio was 1:1. The majority presented with an orbital mass and loss of vision. Twenty-two (60%) of the patients with invasive SCC had enucleation or exenteration as the primary modality of treatment with or without radiotherapy or chemotherapy. Altogether for intraepithelial and invasive squamous neoplasms, the duration of presenting complaints ranged from 1 month to 5 years with an average of 2 years. Human immunodeficiency virus (HIV) infection and smoking were not significantly associated with these cases but a significant number had outdoor occupation. Low socioeconomic status and inability to afford treatment was common among our patients.


CONCLUSIONS
Patients with invasive SCC in Nigeria present late and have significant delay before having any form of treatment. This contributes to the poor outcome. Human papilloma virus (HPV) and actinic aetiology are possible strong causative agents in Nigerians.
Ogun
Gabriel O
GO
Department of Pathology, University College Hospital, Ibadan, Nigeria. olabiyiogun@yahoo.com
Ogun
Olufunmilola A
OA
Bekibele
Charles O
CO
Akang
Effiong E
EE
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D002278:Carcinoma in Situ / Q000150:complications / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D018277:Carcinoma, Mucoepidermoid / Q000150:complications / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D003230:Conjunctival Neoplasms / Q000150:complications / Q000473:pathology* / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009549:Nigeria / Q000453:epidemiology; D012189:Retrospective Studies; D017678:Sex Distribution; D014786:Vision Disorders / Q000209:etiology; D055815:Young Adult
Br J Ophthalmol. 1999 Jan;83(1):98-103
10209445
Cancer. 1972 Aug;30(2):580-7
5051681
Ophthalmologe. 2004 Oct;101(10):1011-6
15185119
Ocul Surf. 2003 Apr;1(2):66-73
17075634
Cornea. 1987;6(2):78-116
3301209
Arch Ophthalmol. 1992 Apr;110(4):525-7
1562262
Ophthalmol Clin North Am. 2005 Mar;18(1):1-13, vii
15763187
Br J Ophthalmol. 1996 Jun;80(6):503-8
8759259
Can J Ophthalmol. 1993 Oct;28(6):287-90
8299055
Lancet. 1990 Jul 7;336(8706):51-2
1973230
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005643
17443606
Arch Soc Esp Oftalmol. 2007 Apr;82(4):237-40
17443430
Eur J Dermatol. 2006 Mar-Apr;16(2):187-9
16581575
Ophthalmologe. 2004 Sep;101(9):941-4
14999411
J Clin Pathol. 1995 Dec;48(12):1106-10
8567996
Pediatr Dev Pathol. 2007 Mar-Apr;10(2):149-52
17378688
Am J Ophthalmol. 1990 Jul 15;110(1):23-7
2164326
Br J Ophthalmol. 2002 Feb;86(2):168-73
11815342
Br J Ophthalmol. 2005 Aug;89(8):942-5
16024839
Yan Ke Xue Bao. 2005 Sep;21(3):152-7
17162853
Surv Ophthalmol. 2006 Sep-Oct;51(5):513-9
16950250
East Afr Med J. 2006 May;83(5):267-70
16866221
Curr Opin Oncol. 2004 Sep;16(5):468-76
15314517
Ophthalmology. 1988 Mar;95(3):318-21
3173999
Afr J Med Med Sci. 2003 Jun;32(2):197-202
15032469
Graefes Arch Clin Exp Ophthalmol. 1993 Apr;231(4):246-8
8486309
Clin Exp Ophthalmol. 2005 Aug;33(4):419-20
16033363
Mutagenesis. 2004 Sep;19(5):399-401
15388813
Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):73-7
9037556
Surv Ophthalmol. 1995 May-Jun;39(6):429-50
7660300
Br J Cancer. 1996 Nov;74(10):1511-3
8932327
Cornea. 2003 Jan;22(1):1-4
12502938
Br J Ophthalmol. 2001 Jan;85(1):110-1
11201940
Arch Ophthalmol. 1997 Jan;115(1):75-8
9006429
Arch Ophthalmol. 1996 Mar;114(3):257-61
8600883
Ophthalmic Plast Reconstr Surg. 2006 Nov-Dec;22(6):498-9
17117119
Community Eye Health. 2003;16(47):37
17491843
Cent Afr J Med. 2003 Jan-Feb;49(1-2):1-4
14562592
East Afr Med J. 1992 Sep;69(9):487-9
1286630
Acta Ophthalmol (Copenh). 1992 Apr;70(2):248-54
1319099
Cornea. 2003 Oct;22(7):687-704
14508267
Int Ophthalmol Clin. 1997 Fall;37(4):73-85
9429933
Am J Clin Pathol. 2004 Dec;122(6):938-43
15539387
Int Ophthalmol Clin. 1993 Summer;33(3):19-24
8407186
Ophthalmologe. 2006 Aug;103(8):693-7
16819663